Research ExplorerPublicationsEvolution of mitral valve procedural volumes in the advent o...

Evolution of mitral valve procedural volumes in the advent of endovascular treatment options: Experience at an early-adopting center in Germany

Standard

Evolution of mitral valve procedural volumes in the advent of endovascular treatment options: Experience at an early-adopting center in Germany. / Conradi, Lenard; Lubos, Edith; Treede, Hendrik; Pietzsch, Jan Benjamin; Weber, Simon; Pietzsch, Malte; Overlack, Karin; Diemert, Patrick; Blankenberg, Stefan; Reichenspurner, Hermann.

In: CATHETER CARDIO INTE, Vol. 86, No. 6, 15.11.2015, p. 1114-1119.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Conradi, L, Lubos, E, Treede, H, Pietzsch, JB, Weber, S, Pietzsch, M, Overlack, K, Diemert, P, Blankenberg, S & Reichenspurner, H 2015, 'Evolution of mitral valve procedural volumes in the advent of endovascular treatment options: Experience at an early-adopting center in Germany', CATHETER CARDIO INTE, vol. 86, no. 6, pp. 1114-1119. https://doi.org/10.1002/ccd.25962

APA

Conradi, L., Lubos, E., Treede, H., Pietzsch, J. B., Weber, S., Pietzsch, M., Overlack, K., Diemert, P., Blankenberg, S., & Reichenspurner, H. (2015). Evolution of mitral valve procedural volumes in the advent of endovascular treatment options: Experience at an early-adopting center in Germany. CATHETER CARDIO INTE, 86(6), 1114-1119. https://doi.org/10.1002/ccd.25962

Vancouver

Conradi L, Lubos E, Treede H, Pietzsch JB, Weber S, Pietzsch M et al. Evolution of mitral valve procedural volumes in the advent of endovascular treatment options: Experience at an early-adopting center in Germany. CATHETER CARDIO INTE. 2015 Nov 15;86(6):1114-1119. https://doi.org/10.1002/ccd.25962

Bibtex

@article{5ac3b14a1fd64c82b6c69f08a9e7d214,
title = "Evolution of mitral valve procedural volumes in the advent of endovascular treatment options: Experience at an early-adopting center in Germany",
abstract = "OBJECTIVES: Our objectives were to assess the evolution of surgical and endovascular mitral valve procedural volumes and to study utilization and reimbursement effects of transcatheter mitral valve repair (TMVR) at our center and to put these in perspective with the corresponding data at the national level.BACKGROUND: TMVR using the MitraClip system has been available in Germany since 2008 as a complementary treatment option for high-risk or inoperable patients.METHODS: Relevant procedure codes were identified for 2006-2012 and yearly utilization volumes obtained from our center's databases and from the national statistics office. Volumes were analyzed in total, and stratified by treatment approach. Procedure reimbursement at our center was determined for years 2007-2012.RESULTS: At our center, 378 MitraClip procedures were performed from 2008 to 2012. During this period, surgical volumes grew at an average of 10.6% annually (2008: 262; 2012: 392; 49.6% total growth rate). Total surgical and TMVR reimbursement increased from EUR 3.8 million (2007) to EUR 7.9 million (2012). By comparison, mitral valve procedural volumes grew by 56.1% from 2006 to 2012 at the national level, with TMVR constituting 9.1% of 20,328 procedures in 2012. Since the introduction of MitraClip, nationwide surgical procedural volumes grew at an average of 6.3% annually (2008: 14,477; 2012: 18,478; 27.6% total growth rate).CONCLUSIONS: Growth in procedural volumes during 2006-2012 reflects an increasing supply and subsequent demand for mitral valve procedures. The introduction of TMVR has contributed to overall growth, and has not reduced continued growth in surgical volumes. Our center-specific analysis suggests a {"}halo effect{"} of an integrated approach to mitral valve disease contributing to additional growth in surgical and overall reimbursement volumes.",
keywords = "Aged, Angioplasty/methods, Cardiac Catheterization, Cohort Studies, Echocardiography, Female, Germany, Health Care Surveys, Heart Valve Prosthesis, Humans, Incidence, Male, Middle Aged, Mitral Valve Insufficiency/diagnostic imaging, Mitral Valve Stenosis/diagnostic imaging, Prognosis, Prosthesis Implantation/methods, Retrospective Studies, Severity of Illness Index, Treatment Outcome",
author = "Lenard Conradi and Edith Lubos and Hendrik Treede and Pietzsch, {Jan Benjamin} and Simon Weber and Malte Pietzsch and Karin Overlack and Patrick Diemert and Stefan Blankenberg and Hermann Reichenspurner",
note = "{\textcopyright} 2015 Wiley Periodicals, Inc.",
year = "2015",
month = nov,
day = "15",
doi = "10.1002/ccd.25962",
language = "English",
volume = "86",
pages = "1114--1119",
journal = "CATHETER CARDIO INTE",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "6",

}

RIS

TY - JOUR

T1 - Evolution of mitral valve procedural volumes in the advent of endovascular treatment options: Experience at an early-adopting center in Germany

AU - Conradi, Lenard

AU - Lubos, Edith

AU - Treede, Hendrik

AU - Pietzsch, Jan Benjamin

AU - Weber, Simon

AU - Pietzsch, Malte

AU - Overlack, Karin

AU - Diemert, Patrick

AU - Blankenberg, Stefan

AU - Reichenspurner, Hermann

N1 - © 2015 Wiley Periodicals, Inc.

PY - 2015/11/15

Y1 - 2015/11/15

N2 - OBJECTIVES: Our objectives were to assess the evolution of surgical and endovascular mitral valve procedural volumes and to study utilization and reimbursement effects of transcatheter mitral valve repair (TMVR) at our center and to put these in perspective with the corresponding data at the national level.BACKGROUND: TMVR using the MitraClip system has been available in Germany since 2008 as a complementary treatment option for high-risk or inoperable patients.METHODS: Relevant procedure codes were identified for 2006-2012 and yearly utilization volumes obtained from our center's databases and from the national statistics office. Volumes were analyzed in total, and stratified by treatment approach. Procedure reimbursement at our center was determined for years 2007-2012.RESULTS: At our center, 378 MitraClip procedures were performed from 2008 to 2012. During this period, surgical volumes grew at an average of 10.6% annually (2008: 262; 2012: 392; 49.6% total growth rate). Total surgical and TMVR reimbursement increased from EUR 3.8 million (2007) to EUR 7.9 million (2012). By comparison, mitral valve procedural volumes grew by 56.1% from 2006 to 2012 at the national level, with TMVR constituting 9.1% of 20,328 procedures in 2012. Since the introduction of MitraClip, nationwide surgical procedural volumes grew at an average of 6.3% annually (2008: 14,477; 2012: 18,478; 27.6% total growth rate).CONCLUSIONS: Growth in procedural volumes during 2006-2012 reflects an increasing supply and subsequent demand for mitral valve procedures. The introduction of TMVR has contributed to overall growth, and has not reduced continued growth in surgical volumes. Our center-specific analysis suggests a "halo effect" of an integrated approach to mitral valve disease contributing to additional growth in surgical and overall reimbursement volumes.

AB - OBJECTIVES: Our objectives were to assess the evolution of surgical and endovascular mitral valve procedural volumes and to study utilization and reimbursement effects of transcatheter mitral valve repair (TMVR) at our center and to put these in perspective with the corresponding data at the national level.BACKGROUND: TMVR using the MitraClip system has been available in Germany since 2008 as a complementary treatment option for high-risk or inoperable patients.METHODS: Relevant procedure codes were identified for 2006-2012 and yearly utilization volumes obtained from our center's databases and from the national statistics office. Volumes were analyzed in total, and stratified by treatment approach. Procedure reimbursement at our center was determined for years 2007-2012.RESULTS: At our center, 378 MitraClip procedures were performed from 2008 to 2012. During this period, surgical volumes grew at an average of 10.6% annually (2008: 262; 2012: 392; 49.6% total growth rate). Total surgical and TMVR reimbursement increased from EUR 3.8 million (2007) to EUR 7.9 million (2012). By comparison, mitral valve procedural volumes grew by 56.1% from 2006 to 2012 at the national level, with TMVR constituting 9.1% of 20,328 procedures in 2012. Since the introduction of MitraClip, nationwide surgical procedural volumes grew at an average of 6.3% annually (2008: 14,477; 2012: 18,478; 27.6% total growth rate).CONCLUSIONS: Growth in procedural volumes during 2006-2012 reflects an increasing supply and subsequent demand for mitral valve procedures. The introduction of TMVR has contributed to overall growth, and has not reduced continued growth in surgical volumes. Our center-specific analysis suggests a "halo effect" of an integrated approach to mitral valve disease contributing to additional growth in surgical and overall reimbursement volumes.

KW - Aged

KW - Angioplasty/methods

KW - Cardiac Catheterization

KW - Cohort Studies

KW - Echocardiography

KW - Female

KW - Germany

KW - Health Care Surveys

KW - Heart Valve Prosthesis

KW - Humans

KW - Incidence

KW - Male

KW - Middle Aged

KW - Mitral Valve Insufficiency/diagnostic imaging

KW - Mitral Valve Stenosis/diagnostic imaging

KW - Prognosis

KW - Prosthesis Implantation/methods

KW - Retrospective Studies

KW - Severity of Illness Index

KW - Treatment Outcome

U2 - 10.1002/ccd.25962

DO - 10.1002/ccd.25962

M3 - SCORING: Journal article

C2 - 25918878

VL - 86

SP - 1114

EP - 1119

JO - CATHETER CARDIO INTE

JF - CATHETER CARDIO INTE

SN - 1522-1946

IS - 6

ER -